FIELD: biotechnology.
SUBSTANCE: invention relates to compounds that are selective allosteric inhibitors of TMLR-, TMLRCS-, LR-, LRCS-containing mutants of EGFR – epidermal growth factor receptor, pharmaceutical compositions containing them, and their use as therapeutically active substances for the treatment of non-small cell lung cancer.
EFFECT: obtaining compounds for the treatment of cancer.
15 cl, 31 ex, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMPURITIES | 2019 |
|
RU2800278C2 |
| PYRIDYLPYRIDONES | 2018 |
|
RU2805334C2 |
| DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES AND RESPIRATORY WAYS DISEASES | 2001 |
|
RU2265011C2 |
| BIARILE MONOBACTAM COMPOUNDS AND METHODS OF THEIR APPLICATION FOR TREATMENT OF BACTERIAL INFECTIONS | 2016 |
|
RU2746129C2 |
| NOVEL COMPOUNDS | 2016 |
|
RU2734256C2 |
| PYRIDAZINE DERIVATIVE INHIBITOR, METHOD OF ITS PREPARATION AND ITS USE | 2020 |
|
RU2807611C2 |
| NOVEL 3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONES AND 2,3-DIHYDRO-ISOINDOLE-1-ONES | 2014 |
|
RU2689421C2 |
| 2,5-DIOXOIMIDAZOLIN-4-YL METHYLCARBONYL COMPOUNDS, METHOD OF OBTAINING THEM, PHARMACEUTICAL MIXTURES CONTAING THEM AND THIR USE IN MEDICINE PREPARATION | 2003 |
|
RU2326117C2 |
| BENZAZEPINE DICARBOXAMIDE COMPOUND | 2016 |
|
RU2712248C2 |
| SPIRO CONDENSED PYRROLIDINE DERIVATIVES AS INHIBITORS OF DEUBIQUITINATING ENZYMES (DUB) | 2017 |
|
RU2730552C2 |
